ISRG: Intuitive Corp Projected Price to Earnings

Brandmark of Intuitive Surgical (ISRG)

Intuitive Surgical (ISRG) is implementing ESG principles by reducing plastic waste and optimizing sterilization processes. Revenues are driven by the supply of consumables and services for clinics. The company's forward P/E for the coming year confirms these trends, with 37.00 serving as the base value of the parameter. A closed ecosystem characterized by high surgeon loyalty and regulatory support ensures steady growth of the procedure base.

ISRG - Intuitive Market Cap to Projected Earnings over the range 07/04/2022 - 11/10/2026

Analytical breakdowns and data insights for company Intuitive Corp (ISRG)

- stock value and consensus price forecast:
Summary company analysis:ISRG Intuitive
Signature product of intuitive.com

Forward P/E determines the market value of a single unit of expected earnings, reflecting investor expectations regarding business growth rates. For Intuitive Surgical (ISRG), this calculation depends directly on the effectiveness of strategic alliances with clinics that expand the adoption of robotics. By analyzing the company's projected P/E metric, one can identify abnormal deviations of the current price from its fundamental value. Sharp fluctuations in the line signal a reassessment of the synergy potential of medical innovations. The final trend helps balance the risk of overpayment against the possibility of undervalued capital growth.

Direct competitors

Future Price to Earnings Danaher (DHR)|Future Price to Earnings BDX (BD)|STERIS Corporation - Projected Price to Earnings|Future Price to Earnings Multiple WST|Baxter International - Forward P/E Multiple|Market Cap to Projected Earnings masimo.com MASI|Stevanato Group (STVN) - Future Price to Earnings|Price to Future Earnings Ratio TFX|Future Price to Earnings Merit Medical Systems Inc|Nobel Biocare (NVST) - Market Cap to Projected Earnings|Projected Price to Earnings ICUI (ICU Medical, Inc.)|Market Cap to Future Earnings Ratio XRAY|Future Price to Earnings LeMaitre Vascular LMAT|Future Price to Earnings Multiple ATRC|STAA: Projected Price to Earnings|NAGE - Forward P/E Multiple|ZimVie Inc. (ZIMV) - Future Price to Earnings|Projected Price to Earnings angiodynamics.com|CERS (Cerus) - Forward P/E Multiple|Projected Price to Earnings Ratio Alpha Teknova TKNO|Future Price to Earnings Monogram Technologies Inc (MGRM)|sharpstechnology.com - Price to Future Earnings Ratio|InfuSystem Holdings, Inc. - Projected Price to Earnings|Market Cap to Future Earnings Ratio UTMD (utahmed.com)|KRMD - Future Price to Earnings|Market Cap to Projected Earnings Nyxoah SA NYXH|MBOT: Forward P/E Multiple|PDEX - Market Cap to Projected Earnings|Future Price to Earnings Zentek Ltd.|Price to Future Earnings Ratio ELUT (elutia.com)|Projected Price to Earnings MLSS (Milestone Scientific Inc.)|Market Cap to Future Earnings Ratio NXGL|Retractable Technologies, Inc. - Projected Price to Earnings|Forward P/E Multiple harvardbioscience.com HBIO|Femasys Inc. - Forward P/E Multiple|Market Cap to Projected Earnings MeihuaMed MHUA|POAI (predictive-oncology.com) - Projected Price to Earnings|CJMB: Market Cap to Future Earnings Ratio|ATRI (Atrion Corp) - Forward P/E Multiple|NeuroMetrix Corporation (NURO) - Market Cap to Projected Earnings